Concepedia

Yunlong Lu

YL

16

Publications

757

Citations

14

H-Index

2013

Active since

Affiliations

Nanjing University of Chinese Medicine(Current)

Nanjing University

Dali University

China Pharmaceutical University

Shanxi Medical University

Yunlong Lu is an author at Nanjing University of Chinese Medicine specializing in radiation oncology, medicine, and medicinal chemistry.

ORCID

Top concepts

Publications per year

2013–2025

16

Publications

16

Mecheliolide elicits ROS-mediated ERS driven immunogenic cell death in hepatocellular carcinoma

Zhongren Xu, Jianqiang Xu, Shibo Sun et al. · Redox Biology · 2022 · 131 citations · Full text

Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for Estrogen Receptor Positive Endocrine-Resistant Breast Cancer

Yunlong Lu, Wukun Liu · Journal of Medicinal Chemistry · 2020 · 97 citations · Full text

Pt(II)-NHC Complex Induces ROS-ERS-Related DAMP Balance to Harness Immunogenic Cell Death in Hepatocellular Carcinoma

Mianli Bian, Rong Fan, Zhibin Yang et al. · Journal of Medicinal Chemistry · 2022 · 73 citations

Induction of immunogenic cell death by novel platinum-based anticancer agents

Xingyu Chang, Mianli Bian, Lijuan Liu et al. · Pharmacological Research · 2022 · 65 citations · Full text

, , +18

Halo and Pseudohalo Gold(I)–NHC Complexes Derived from 4,5-Diarylimidazoles with Excellent <i>In Vitro</i> and <i>In Vivo</i> Anticancer Activities Against HCC

Mianli Bian, Rong Fan, Guizhi Jiang et al. · Journal of Medicinal Chemistry · 2020 · 57 citations

Rows per page

1–5 of 16